Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ZYDUS LIFESCIENCES ALKEM LABORATORIES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 37.3 34.5 107.9% View Chart
P/BV x 6.5 5.8 111.4% View Chart
Dividend Yield % 1.0 0.6 172.2%  

Financials

 ALKEM LABORATORIES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ZYDUS LIFESCIENCES
Mar-23
ALKEM LABORATORIES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs3,625495 732.4%   
Low Rs2,835319 887.6%   
Sales per share (Unadj.) Rs970.1170.3 569.6%  
Earnings per share (Unadj.) Rs84.219.8 425.7%  
Cash flow per share (Unadj.) Rs110.226.9 409.3%  
Dividends per share (Unadj.) Rs50.006.00 833.3%  
Avg Dividend yield %1.51.5 105.0%  
Book value per share (Unadj.) Rs756.4173.0 437.1%  
Shares outstanding (eoy) m119.571,012.20 11.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.4 139.3%   
Avg P/E ratio x38.420.6 186.3%  
P/CF ratio (eoy) x29.315.1 193.8%  
Price / Book Value ratio x4.32.4 181.5%  
Dividend payout %59.430.3 195.7%   
Avg Mkt Cap Rs m386,207412,144 93.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31424,564 86.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993172,374 67.3%  
Other income Rs m2,1614,746 45.5%   
Total revenues Rs m118,153177,120 66.7%   
Gross profit Rs m15,06529,677 50.8%  
Depreciation Rs m3,1047,227 43.0%   
Interest Rs m1,0741,299 82.6%   
Profit before tax Rs m13,04825,897 50.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9805,878 50.7%   
Profit after tax Rs m10,06820,019 50.3%  
Gross profit margin %13.017.2 75.4%  
Effective tax rate %22.822.7 100.6%   
Net profit margin %8.711.6 74.7%  
BALANCE SHEET DATA
Current assets Rs m86,064100,082 86.0%   
Current liabilities Rs m37,07155,267 67.1%   
Net working cap to sales %42.226.0 162.5%  
Current ratio x2.31.8 128.2%  
Inventory Days Days3350 64.8%  
Debtors Days Days6794 71.7%  
Net fixed assets Rs m37,245144,776 25.7%   
Share capital Rs m2391,012 23.6%   
"Free" reserves Rs m90,208174,146 51.8%   
Net worth Rs m90,447175,158 51.6%   
Long term debt Rs m00-   
Total assets Rs m124,541244,940 50.8%  
Interest coverage x13.220.9 62.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.7 132.3%   
Return on assets %8.98.7 102.8%  
Return on equity %11.111.4 97.4%  
Return on capital %15.615.5 100.6%  
Exports to sales %14.639.2 37.2%   
Imports to sales %011.9 0.0%   
Exports (fob) Rs m16,91667,577 25.0%   
Imports (cif) Rs mNA20,544 0.0%   
Fx inflow Rs m16,91667,577 25.0%   
Fx outflow Rs m4,19020,544 20.4%   
Net fx Rs m12,72747,033 27.1%   
CASH FLOW
From Operations Rs m16,82526,888 62.6%  
From Investments Rs m1,12811,712 9.6%  
From Financial Activity Rs m-17,608-44,004 40.0%  
Net Cashflow Rs m416-5,338 -7.8%  

Share Holding

Indian Promoters % 56.7 75.0 75.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 18.0 135.3%  
FIIs % 8.5 5.0 170.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 25.0 172.9%  
Shareholders   65,184 306,495 21.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ALKEM LABORATORIES vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Cadila Healthcare Share Price Performance

Period ALKEM LABORATORIES Cadila Healthcare S&P BSE HEALTHCARE
1-Day -1.85% 1.42% 1.18%
1-Month -1.67% 8.68% -0.75%
1-Year 51.22% 109.28% 61.82%
3-Year CAGR 21.42% 32.67% 18.16%
5-Year CAGR 22.82% 24.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.